(EMAILWIRE.COM, February 08, 2019 ) Chronic total occlusion (CTO) occurs when a coronary artery is completely blocked with plaque for more than three months. CTO obstructs the flow of blood to the heart and can have severe effects on the health. When one or more of coronary arteries are completely blocked, the patients are at higher risk for a heart attack. A percutaneous coronary interventional (PCI) procedure is the appropriate treatment option for patients that have poor blood flow through one or more coronary arteries.

Chronic total occlusion market is segmented by equipment and end user. Global Chronic total occlusion market, based on equipment the segment is segmented as micro catheters, guide wires, crossing devices and re-entry devices. The chronic total occlusion market, based on end user was segmented into hospitals, ambulatory care centers, and others.

Get sample PDF copy at: http://bit.ly/2TE1twC

The objective of the study is to describe, define, and forecast the chronic total occlusion market by equipment, end user and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall market.

The report analyzes factors affecting chronic total occlusion market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The report also includes the profiles of key chronic total occlusion manufacturing companies along with their SWOT analysis and market strategies.

The prominent players operating in the market of chronic total occlusion across the globe includes ASAHI INTECC CO., LTD, SoundBite Medical Solutions, Integer Holdings Corporation, Baylis Medical Company, Inc, SPECTRANETICS, C. R. Bard, Inc., Boston Scientific Corporation, Medtronic, Terumo Corporation, Cordis, and Abbott among others. For instance, in April 2018, Asahi Intecc started direct sales of its coronary (PTCA) guide wires in the US. In March 2018, Soundbite medical soultions received CE Marking for the SoundBite Crossing System, a unique and novel first-in-class wire-based technology that is intended for the treatment of peripheral chronic total occlusions (CTOs) in a simpler and clinically efficient method. Thus enhancing its business in global chronic total occlusion market.


Buy Now at: http://bit.ly/2TE1DUK

Contact Information:
The Insight Partners
Sameer Joshi
Tel: +1-646-491-9876
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results